Notice 21 Apr 2025 compliance, healthcare, dea, legal, tennessee, drug enforcement, medicine

⚖️DEA Revokes Registration of Dr. John Stanton Due to Legal Issues

The Drug Enforcement Administration (DEA) issued an Order to Show Cause against Dr. John Stanton, proposing to revoke his registration due to the loss of state medical authority. The decision directly relates to his felony conviction and the revocation of his medical license in Tennessee, thereby blocking his ability to dispense controlled substances.

Learn More
Notice 18 Apr 2025 compliance, regulation, dea, controlled substances, drug manufacturing, stepan company

⚗️Stepan Company Seeks Registration as Bulk Manufacturer of Controlled Substances

Stepan Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 18 Apr 2025 regulatory compliance, pharmaceuticals, research, dea, controlled substances, scottsdale

💊Notice for Controlled Substances Importer Application by Scottsdale Research Institute

Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 compliance, pharmaceuticals, clinical trials, dea, controlled substances, drug enforcement, myonex llc

💊Notice of Application for Controlled Substances by Myonex LLC

Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 16 Apr 2025 compliance, healthcare, regulation, nevada, dea, drug enforcement, medical licensing

⚖️DEA Revocation of Registration

The Drug Enforcement Administration (DEA) revoked Ajumobi Agu, M.D.'s registration due to sustained illegal activity, including dispensing controlled substances without appropriate licenses. The order emphasizes the importance of compliance with both federal and state laws in the healthcare field, and the potential consequences for practitioners engaged in similar misconduct.

Learn More
Notice 16 Apr 2025 healthcare compliance, dea, florida, drug enforcement, registration revocation, medical regulations

⚖️DEA Revokes Registration of Victor Augusto Silva, M.D.

The Drug Enforcement Administration has revoked the registration of Dr. Victor Augusto Silva due to violations that allowed an unauthorized individual to prescribe controlled substances. This decision underscores the strict compliance required under federal and Florida laws regarding the use of DEA registrations and the serious implications of non-compliance for medical practitioners.

Learn More
Notice 16 Apr 2025 regulatory compliance, new york, dea, controlled substances, drug enforcement administration, medical practice

⚖️DEA Revokes Registration of David Israel, M.D. for Misconduct

The Drug Enforcement Administration issued an order revoking David Israel, M.D.’s DEA registration due to unlawful prescription practices outside the usual course of professional practice. Allegations include issuing prescriptions for controlled substances without legitimate medical purpose, leading to significant legal and operational implications for the medical professional.

Learn More
Notice 16 Apr 2025 regulatory compliance, healthcare, georgia, dea, controlled substances, dentistry

⚖️DEA Suspends Dentist's Registration Over Compliance Violations

The Drug Enforcement Administration has issued an Order to Show Cause and suspended the registration of Lona Bibbs-Walker, D.D.S., citing inadequate records on controlled substances and lack of state authority to practice. The order illustrates critical compliance issues in the healthcare industry, emphasizing the importance of strict adherence to regulatory standards.

Learn More
Notice 14 Apr 2025 compliance, regulation, texas, dea, controlled substances, pharmacy

💊DEA Revocation of Mariste Pharmacy's Registration - Overview

The Drug Enforcement Administration (DEA) has issued a decision revoking Mariste Pharmacy's registration due to significant violations related to controlled substances. Allegations include failure to address red flags of abuse in prescriptions and inadequate record-keeping, raising concerns for regulatory compliance and public health. The decision emphasizes the importance of adherence to laws governing drug dispensing and security.

Learn More
Notice 14 Apr 2025 regulatory compliance, pharmaceutical industry, texas, dea, controlled substances

💊DEA Revokes Eagle Pharmacy Registration

The Drug Enforcement Administration issued an Order to Show Cause against Eagle Pharmacy for alleged violations related to dispensing controlled substances without addressing significant red flags of abuse. The case highlights the stringent regulations governing pharmacies and the potential consequences of non-compliance, including revocation of licenses and operational disruptions.

Learn More